Throughout several populations, ACE2 polymorphisms have been associated with susceptibility to cardiovascular and metabolic diseases including hypertension and type 2 diabetes mellitus underlining the potential functional impact of these SNPs on ACE2 expression and/or function (13–21). Here, ACE2 is linked to metabolic disease.